SCHEMBL16357482

SCHEMBL16357482

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c5ccn(-c6ccccc6)c5ccc43)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.35
L3MBTL1 Q9Y468 4/20 0.35
MAPT P10636 3/20 0.35
MAPK1 P28482 3/20 0.35
NPSR1 Q6W5P4 3/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ATM Q13315 1/20 0.35
CYP11B1 P15538 2/20 0.35
CYP17A1 P05093 1/20 0.35
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 2/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15801821 0.95 L3MBTL1 (0.35) CYP19A1L3MBTL1MAPTMAPK1NPSR1
SCHEMBL15632104 0.93 CYP19A1 (0.33) CYP19A1L3MBTL1MAPTMAPK1NPSR1
SCHEMBL15213513 0.90 MAPT (0.38) CYP19A1L3MBTL1MAPTMAPK1NPSR1
SCHEMBL17017634 0.89 KDM4E (0.36) CYP19A1L3MBTL1MAPTMAPK1NPSR1
SCHEMBL15632103 0.87 KDM4E (0.37) L3MBTL1MAPTNPSR1HTTKDM4E
SCHEMBL16357384 0.87 KDM4E (0.37) L3MBTL1NPSR1KDM4EATMMEN1
SCHEMBL15213688 0.87 L3MBTL1 (0.33) CYP19A1L3MBTL1MAPTMAPK1NPSR1
SCHEMBL16357414 0.87 KMT2A (0.40) CYP19A1L3MBTL1MAPTMAPK1NPSR1
SCHEMBL15213708 0.87 KMT2A (0.40) CYP19A1L3MBTL1MAPTMAPK1NPSR1
SCHEMBL15632140 0.87 KDM4E (0.44) L3MBTL1MAPK1HTTKDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 US disclosed
US-20140374724-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU CYP19A1 870/4885L3MBTL1 464/4885MAPT 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.